ライフサイエンスコーパス: sodium fluoride

1 ine fluoride, sodium monofluorophosphate, or sodium fluoride).

2 ET with [(18)F]fluorodeoxyglucose and [(18)F]sodium fluoride.

3 phatase 2A and sensitive to okadaic acid and sodium fluoride.

4 sphatase inhibitors sodium orthovanadate and sodium fluoride.

5 tally benign mixture of elemental carbon and sodium fluoride.

6 ide and 2.6% EDTA or a dentifrice with 0.24% sodium fluoride.

7 tested versus a positive control dentifrice (sodium fluoride/0.30% triclosan/copolymer) in 440 medica

8 ce of phosphatase inhibitors including 50 mM sodium fluoride, 1 mM okadaic acid, and 0.5 mM calyculin

9 sitron emission tomography (PET) using (18)F-sodium fluoride ((18)F-fluoride) to detect microcalcific

10 Coronary (18)F-sodium fluoride ((18)F-fluoride) uptake is a marker of b

11 accumulation of radiotracers, such as (18)F-sodium fluoride ((18)F-NaF) and (18)F-FDG.

12 plaques using the radioactive tracers (18)F-sodium fluoride ((18)F-NaF) and (18)F-fluorodeoxyglucose

13 acquisition 1 h after the injection of (18)F-sodium fluoride ((18)F-NaF) at 248 +/- 10 MBq (mean +/-

14 T/CT) imaging of atherosclerosis using (18)F-sodium fluoride ((18)F-NaF) has the potential to identif

15 (18)F-sodium fluoride ((18)F-NaF) is a positron emission tomog

16 Coronary (18)F-sodium fluoride ((18)F-NaF) PET and CT angiography-based

17 Background MRI and fluorine 18-labeled sodium fluoride ((18)F-NaF) PET can be used to identify

18 max) >2.0 m/s), who underwent baseline (18)F-sodium fluoride ((18)F-NaF) positron emission tomography

19 Coronary (18)F-sodium fluoride ((18)F-NaF) positron emission tomography

20 , computed tomography angiography, and (18)F-sodium fluoride ((18)F-NaF) positron emission tomography

21 18F-Sodium fluoride (18F-NaF) and 18F-fluorodeoxyglucose (18

22 investigated coronary arterial uptake of 18F-sodium fluoride (18F-NaF) and 18F-fluorodeoxyglucose (18

23 ion in the aortic valve were assessed by 18F-sodium fluoride (18F-NaF) and 18F-fluorodeoxyglucose (18

24 nt groups included control, Spirulina alone, sodium fluoride (20 mg/kg) alone, and sodium fluoride al

25 toxin-insensitive and was not additive with sodium fluoride, a cell-permeant activator of heterotrim

26 alone, sodium fluoride (20 mg/kg) alone, and sodium fluoride along with Spirulina (250 and 500 mg/kg)

27 of (99m)Tc-labeled diphosphonates and (18)F-sodium fluoride and discusses and compares the performan

28 dine, menthol, triclosan, methyl salicylate, sodium fluoride and povidone, against two important prot

29 nriched in magnesium flanking a core rich in sodium, fluoride and carbonate ions; this sandwich core

30 ontaining 8% strontium acetate and 1,040 ppm sodium fluoride; and 3) containing 30% microaggregation

31 change in peak aortic jet velocity or (18)F-sodium fluoride aortic valve uptake.

32 stannous fluoride and 2.6% EDTA (D1), 0.24% sodium fluoride (C), and 0.454% stannous fluoride (D2-D4

33 herefore predisposed to MAC, underwent (18)F-sodium fluoride (calcification activity) and (18)F-Fluor

34 A 16-h exposure to sodium fluoride caused decreased expression of proteins

35 de stabilized with zinc phosphate (test) and sodium fluoride (control) dentifrices.

36 givitis compared to a commercially available sodium fluoride dentifrice.

37 btype, whereas basal levels and responses to sodium fluoride did not change.

38 ificantly by increasing the concentration of sodium fluoride during the polymerization.

39 ith the aid of repeated PET imaging (FMT and sodium fluoride for bone), realignment to subsequent com

40 yclase activity stimulated by isoproterenol, sodium fluoride, guanyl-5'-imidodiphosphate, and forskol

41 of the pyrophosphatase activity of NURF with sodium fluoride has no significant effect on chromatin r

42 anning revealed diminished uptake of [(18)F]-sodium fluoride in the growth plate area, consistent wit

43 Na2WO4 and sodium fluoride increased the relative amount of the 1-p

44 the role of Spirulina platensis in reversing sodium fluoride-induced thyroid, neurodevelopment and ox

45 te 1 to a state 2 chemically locked by 0.1 M sodium fluoride leads to an almost complete functional r

46 e activity was inhibited by sodium vanadate, sodium fluoride, N-ethylmaleimide, and phenylglyoxal but

47 tively assessed the impact of PET with (18)F-sodium fluoride (NaF PET) on intended management of Medi

48 Evidence Development policy, PET using (18)F-sodium fluoride (NaF PET) to identify osseous metastasis

49 mprising of sodium oxynitrides (NaN(x)O(y)), sodium fluoride (NaF) and phosphorus oxide compounds (Na

50 We evaluated the kinetics of (18)F-sodium fluoride (NaF) and reassessed the recommended dos

51 ation of degradation species: newly observed sodium fluoride (NaF) and the expected sodium carbonate

52 We have also employed sodium fluoride (NaF) as a solvent dopant to enhance the

53 n the absence of any organic solvent to form sodium fluoride (NaF) in 98% yield.

54 Within the SEI, sodium fluoride (NaF) is more prevalent with Te-Cu versu

55 examine the potential genotoxic influence of sodium fluoride (NaF) on mammalian cells by means of a m

56 valuate the interobserver agreement in (18)F-sodium fluoride (NaF) PET/CT for the detection of bone m

57 Purpose [(18)F]Sodium fluoride (NaF) positron emission tomography (PET)

58 c effects, and changes in quantitative (18)F-sodium fluoride (NaF) positron emission tomography/compu

59 g dentin hypersensitivity (DH) compared to a sodium fluoride (NaF) toothpaste over a 2-week period.

60 (1) (18)F-fluorodeoxyglucose (FDG) and (18)F-sodium fluoride (NaF) uptake in culprit versus nonculpri

61 k meta-analyses suggested that sealants + 5% sodium fluoride (NaF) varnish, resin infiltration + 5% N

62 e effect of calcium and phosphate-containing sodium fluoride (NaF) varnishes to conventional NaF varn

63 ilities of silver diamine fluoride (SDF) and sodium fluoride (NaF).

64 of tannic acid (TA), silk fibroin (SF), and sodium fluoride (NaF).

65 ussis toxin, dose response relationships for sodium fluoride (NaF; range, 0.1-4 mmol/L), a Gi protein

66 valent levels of fluoride (F) in the form of sodium-fluoride (NaF).

67 inhibitors of serine/threonine phosphatases (sodium fluoride, okadaic acid, and microcystin LR).

68 inhibited by sodium orthovanadate but not by sodium fluoride or okadaic acid.

69 Treatment of hTMC with sodium fluoride or ouabain, agents shown to cause morpho

70 rs (5 mmol/l sodium orthovanadate, 50 mmol/l sodium fluoride, or 5 mmol/l EDTA, but not 100 nmol/l ok

71 y, we previously studied the impact of (18)F-sodium fluoride PET (NaF PET) on the intended management

72 ssess skeletal tumor burden with 18F-labeled sodium fluoride PET/CT (18F-fluoride PET/CT) and evaluat

73 s study was to determine if additional (18)F-sodium fluoride PET/CT (NaF PET/CT) improves the prognos

74 Conclusion Fluorine 18-labeled sodium fluoride PET/MRI characteristics were associated

75 ification activity can be detected using 18F-sodium fluoride positron emission tomography (18F-NaF PE

76 c resonance imaging (n = 3), and fluorine-18 sodium fluoride positron emission tomography (PET) (n =

77 aphy aortic valve calcium scoring, and (18)F-sodium fluoride positron emission tomography and compute

78 Coronary 18F-sodium fluoride positron emission tomography and coronar

79 esponse to valvular inflammation using (18)F-sodium fluoride positron emission tomography represents

80 lerotic plaque activity using coronary (18)F-sodium fluoride positron emission tomography to identify

81 he coronary microcalcification activity (18F-sodium fluoride positron emission tomography/computed to

82 )Tc-labeled diphosphonates and (18)F-labeled sodium fluoride provides functional information sensitiv

83 luence of a number of salts (sodium sulfate, sodium fluoride, sodium acetate, and sodium chloride) on

84 hloride, potassium chloride, sodium acetate, sodium fluoride, sodium dodecyl sulfate (SDS), and manga

85 lly available fluoride dentifrice containing sodium fluoride/sodium monofluorophosphate (NaMFP).

86 on nanoelectrospray ionization of an aqueous sodium fluoride solution in the presence of gas-phase ca

87 ing dentifrices containing strontium acetate/sodium fluoride (SrAc2F) and potassium chloride/sodium m

88 ion or glycolytic inhibitors iodoacetate and sodium fluoride synergistically cooperated with NDI, thu

89 nhibitor combo consisting of tannic acid and sodium fluoride (TA-NaF), which exhibits clear synergist

90 95% CI, 101-467] Agatston units), and [(18)F]sodium fluoride target-to-background ratio(max) (+0.17 [

91 in preventing CAL and root caries versus the sodium fluoride/triclosan/copolymer control in xerostomi

92 cium score), and biological features ([(18)F]sodium fluoride uptake on positron emission tomography-c

93 Increased (18)F-sodium fluoride uptake was found in 679 of 2,094 coronar

94 clerotic plaque activity was assessed by 18F-sodium fluoride uptake.

95 es with a secondary amine in the presence of sodium fluoride using hydroquinine as chiral catalyst wa

96 PET and SPECT, with fluorine-18 sodium fluoride, were performed sequentially in a cylind